The last few years have brought several new therapeutic options into the world of COPD, with even more on the horizon. This webinar looks at current best practices in managing COPD symptoms, including pharmacologic and non-pharmacologic options, and provides insights on designing the optimal treatment plan for your patient.
Speaker: Michael W. Hess, MPH, RRT, RPFT, Senior Director of Advocacy and Regulatory Affairs, COPD Foundation
This session is supported through unrestricted educational grants secured by AARC. All content was developed and delivered independently.
This activity, through the AARC was supported through grants from: Verona Pharma, Viatris, Takeda, Grifols, Olympus and Linde.
Approved for 1.00 CRCE Hours.
SEMINAR OBJECTIVES
o Participants will be able to explain the indications and contraindications for oxygen therapy and inhaled corticosteroids in COPD.
o Participants will be able to recommend appropriate pharmacological interventions for COPD patients, based on the severity of their disease and the presence of comorbidities.
o Participants will be able to develop a comprehensive pulmonary rehabilitation plan for COPD patients, tailored to their individual needs and goals.
o Participants will be able to select the most appropriate bronchodilator for a given COPD patient, considering their symptoms and disease severity.
o Participants will be able to evaluate the risks and benefits of LABAs and LAMAs in COPD management.